Advancing research on a common form of dementia
Mayo Clinic researchers have assembled a team of international experts to investigate key proteins involved in Lewy body dementia.
Lewy Body Dementia Center Without Walls
Investigators from Mayo Clinic s Florida campus are leading a Lewy Body Dementia Center Without Walls research initiative funded by a National Institutes of Health (NIH) specialized center-cooperative agreement grant (U54). The overall goal of the Lewy body dementia multi-institutional Center Without Walls (CWOW) initiative is to deepen the understanding of how the Alzheimer s disease-related protein, amyloid-beta, and the Parkinson s disease-related protein, alpha-synuclein, interact to affect symptom presentation, disease progression and the underlying disease process in Lewy body dementia (LBD).